Stryker has acquired Cerus Endovascular, the devicemaker said May 2.
Cerus Endovascular’s portfolio includes multiple CE marked products which will bolster Stryker’s aneurysm treatment business, according to a news release.
“The acquisition of Cerus Endovascular is highly complementary to Stryker’s Neurovascular business, and strengthens our hemorrhagic portfolio globally,” Jim Marucci, president of Stryker’s neurovascular division, said in the release.
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Spinal device company Alphatec has commercially launched its Prone TransPsoas corpectomy system. The launch marks the expansion of Alphatec’s deformity…
Comments are closed.